The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Step Michael D since 2006.
The trader's CIK number is 1316386.
At the time of the last reporting, Step Michael D was the SVP, Corporate Devel of Ritter Pharmaceuticals Inc. (stock ticker symbol RTTR).
Also see all insider trading activities at Ritter Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | RTTR | 13,000 | $8,008 | 0 | $0 | 0 | $0 |
| 2016 | RTTR | 27,000 | $39,960 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | SNTS | 0 | $0 | 121,206 | $2,397,369 | 99,854 | $117,826 |
| 2006 | SNTS | 3,000 | $19,500 | 0 | $0 | 0 | $0 |
1. Ritter Pharmaceuticals Inc (RTTR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-11 | RTTR | Buy | 13,000 | .62 | 8,008 |
| 2016-01-07 | RTTR | Buy | 27,000 | 1.48 | 39,960 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-09-05 | SNTS | Option Ex | 30,303 | 1.18 | 35,757 |
| 2013-09-05 | SNTS | Sale | 30,303 | 23.17 | 702,181 |
| 2013-07-05 | SNTS | Sale | 30,301 | 21.76 | 659,410 |
| 2013-07-05 | SNTS | Option Ex | 30,301 | 1.18 | 35,755 |
| 2013-05-06 | SNTS | Option Ex | 30,301 | 1.18 | 35,755 |
| 2013-05-06 | SNTS | Sale | 30,301 | 18.73 | 567,689 |
| 2013-03-05 | SNTS | Option Ex | 8,949 | 1.18 | 10,559 |
| 2013-03-05 | SNTS | Sale | 30,301 | 15.45 | 468,089 |
| 2006-03-16 | SNTS | Buy | 3,000 | 6.50 | 19,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Step Michael D (SVP, Corporate Devel of Ritter Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.